We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Molecular Mimicry Enhances Early Viral Infection

By Biotechdaily staff writers
Posted on 16 May 2003
Researchers have found that early infection of T-cells by the human T-lymphotrophic virus-1 (HTLV-1) is enhanced because a section or motif of the HTLV-1 p12 protein is identical to a motif in the human calcium regulatory protein NFAT (nuclear factor of activated T-cells). More...


HTLV-1 is the viral cause of adult T-cell lymphoma, as well as at least two forms of neurologic disease. Investigators from Ohio State University (Columbus, USA; www.osu.edu) studying the molecular mechanism by which the virus successfully invades cells normally capable of resisting infection found that the HTLV-1 p12 protein caused T-lymphocytes to change from a normal resting state to an active state, thereby speeding up cell division which, in turn, allowed the virus to replicate. These findings were published in the May 2, 2003, issue of the Journal of Biological Chemistry.

Understanding of the mechanism came when it was found that a portion or motif of p12 was identical to a motif in a well-known cell protein called Nuclear Factor of Activated T-cells, or NFAT. This section of NFAT controls its binding to calcineurin, an enzyme that regulates calcium signals in T-cells.

"NFAT is a transcription factor that plays a critical role in all cells by binding to the enzyme calcineurin,” explained senior author Dr. Michael Lairmore, professor and chair of veterinary biosciences at Ohio State. "Once bound, it removes a phosphate group from the enzyme, allowing it to travel from the cell's cytoplasm into the nucleus. Once there, the cell becomes activated and begins the process of replication.”

The virus takes advantage of this burst of cell division to subvert the replicatory machinery and manufacture new virus particles.



Related Links:
Ohio State University

Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Procalcitonin Test
LIAISON B•R•A•H•M•S PCT II GEN
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.